Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Marco Ruella(Parker Institute for Cancer Immunotherapy), Jun Xu(University of Pennsylvania), David M. Barrett(Children's Hospital of Philadelphia), Joseph A. Fraietta(Parker Institute for Cancer Immunotherapy), Tyler J. Reich(University of Pennsylvania), David E Ambrose(University of Pennsylvania), Michael Klichinsky(Translational Therapeutics (United States)), Olga Shestova(University of Pennsylvania), Prachi Patel(University of Pennsylvania), Irina Kulikovskaya(University of Pennsylvania), Farzana Nazimuddin(University of Pennsylvania), Vijay Bhoj(University of Pennsylvania), Elena J. Orlando(Novartis (United States)), Terry J. Fry(Children's Hospital Colorado), Hans Bitter(Novartis (United States)), Shannon L. Maude(Children's Hospital of Philadelphia), Bruce L. Levine(University of Pennsylvania), Christopher L. Nobles(University of Pennsylvania), Frederic D. Bushman(University of Pennsylvania), Regina M. Young(University of Pennsylvania), John Scholler(University of Pennsylvania), Saar Gill(University of Pennsylvania), Carl H. June(Parker Institute for Cancer Immunotherapy), Stephan A. Grupp(Children's Hospital of Philadelphia), Simon F. Lacey(University of Pennsylvania), J. Joseph Melenhorst(University of Pennsylvania)
Nature Medicine
September 27, 2018
Cited by 640Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis